Skip to Main Content

Author Details

Ana Pati??o-Garc??a
Center for Applied Medical Research.
1995
154
39
PMIDPaper TitleJournal TitlePublished Year
35975805Primary trimethylaminuria syndrome: more than an unpleasant odor.Int J Dermatol2023
35975805Primary trimethylaminuria syndrome: more than an unpleasant odor.Int J Dermatol2023
36436516Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.Lancet Oncol2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37820087Promises of oncolytic viral therapy for adult and children with brain glioma.Curr Opin Oncol2023
37802053TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.Cancer Cell2023
37566035Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.Cells2023
36712139Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk.bioRxiv2023
36805510Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing.Sci Rep2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37802053TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.Cancer Cell2023
37820087Promises of oncolytic viral therapy for adult and children with brain glioma.Curr Opin Oncol2023
37566035Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.Cells2023
36712139Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk.bioRxiv2023
36436516Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.Lancet Oncol2023
36805510Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing.Sci Rep2023
34965961Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.Mol Cancer Ther2022
35844738Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation.Front Pediatr2022
35393952Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.JCI Insight2022
35767439Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.N Engl J Med2022
35949950Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.Mol Ther Oncolytics2022
36438828<i>SLC7A8</i> coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.Front Pharmacol2022
35267543The BRCA Gene in Epithelial Ovarian Cancer.Cancers (Basel)2022
34965961Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.Mol Cancer Ther2022
35152364Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).Clin Transl Oncol2022
35844738Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation.Front Pediatr2022
35767439Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.N Engl J Med2022
35393952Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.JCI Insight2022
36438828<i>SLC7A8</i> coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.Front Pharmacol2022
35949950Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.Mol Ther Oncolytics2022
35152364Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).Clin Transl Oncol2022
35267543The BRCA Gene in Epithelial Ovarian Cancer.Cancers (Basel)2022
33376098Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.Clin Cancer Res2021
34076861The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).Clin Transl Oncol2021
34281988CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.J Immunother Cancer2021
33792916Additional causal SNRPE mutations in hereditary hypotrichosis simplex.Br J Dermatol2021
33889513Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.Transl Lung Cancer Res2021
34199109Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure.J Pers Med2021
33919355RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models.Cancers (Basel)2021
33376098Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.Clin Cancer Res2021
34771600Clinical Value of NGS Genomic Studies for Clinical Management of Pediatric and Young Adult Bone Sarcomas.Cancers (Basel)2021
33792916Additional causal SNRPE mutations in hereditary hypotrichosis simplex.Br J Dermatol2021
33919355RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models.Cancers (Basel)2021
33889513Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma.Transl Lung Cancer Res2021
34771600Clinical Value of NGS Genomic Studies for Clinical Management of Pediatric and Young Adult Bone Sarcomas.Cancers (Basel)2021
34076861The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).Clin Transl Oncol2021
34199109Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure.J Pers Med2021
34281988CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.J Immunother Cancer2021
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
  • 1 - 50 of 308

Recommended Authors

Malak Abedalthagafi
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 3
Julien Masliah-Planchon
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 10
Chimene Kesserwan
National Institutes of Health
Career Start Year 2007
Number of shared co-authors 6
Alessandro Raso
Giannina Gaslini Institute
Career Start Year 2003
Number of shared co-authors 4
Franck Bourdeaut
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Career Start Year 2001
Number of shared co-authors 14
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 18
Shahrad Rod Rassekh
British Columbia Children's Hospital, The University of British Columbia
Career Start Year 1998
Number of shared co-authors 2
Lawrence J Jennings
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 3
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Karoly Szuhai
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 17
Donald W Parsons
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 15
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 5
Gudrun Schleiermacher
Institut Curie
Career Start Year 1994
Number of shared co-authors 17
Wilson A Silva
Ribeirao Preto Medical School - University of Sao Paulo
Career Start Year 1994
Number of shared co-authors 2
Doris Steinemann
Hannover Medical School
Career Start Year 1994
Number of shared co-authors 27
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 2
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 8
Michael Weintraub
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 3
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Career Start Year 1991
Number of shared co-authors 14
Sharon Abish
McGill University
Career Start Year 1990
Number of shared co-authors 0
Laurence Brugi??res
Universite Paris-Saclay
Career Start Year 1988
Number of shared co-authors 23
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 4
Daniel Sinnett
Sainte-Justine University Hospital Research Center
Career Start Year 1986
Number of shared co-authors 6
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1983
Number of shared co-authors 22
Norbert Graf
Clinical Trials Unit
Career Start Year 1983
Number of shared co-authors 7
Sharon E Plon
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 17
David Malkin
Hospital for Sick Children
Career Start Year 1976
Number of shared co-authors 38
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 38

Collaborators

Luis Sierrases??maga
Clinica Universidad de Navarra
Co-authored papers 41
Marta M Alonso
CIMA-Universidad de Navarra
Co-authored papers 24
Fernando Lecanda
University of Navarra, Center for Applied Medical Research
Co-authored papers 23
Lisa Mirabello
National Cancer Institute
Co-authored papers 14
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 14
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers 12
Sharon A Savage
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 12
Juan Fueyo
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 11
Candelaria Gomez-Manzano
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 11
Robert N Hoover
National Cancer Institute
Co-authored papers 11
Margaret A Tucker
National Cancer Institute
Co-authored papers 11
Jay S Wunder
University of Toronto
Co-authored papers 10
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 9
Richard Gorlick
University of Texas MD Anderson Cancer Center
Co-authored papers 9
Massimo Serra
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 8
Irene L Andrulis
University of Toronto
Co-authored papers 8
Donald A Barkauskas
Keck School of Medicine of the University of Southern California
Co-authored papers 8
Claudia Maria Hattinger
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 7
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers 7
Sonja I Berndt
Co-authored papers 7
Maria Teresa Landi
National Cancer Institute
Co-authored papers 7
Neil E Caporaso
National Cancer Institute, National Institutes of Health
Co-authored papers 7
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers 7
Joseph F Fraumeni
National Cancer Institute
Co-authored papers 7
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 7
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Co-authored papers 7
Logan G Spector
Division of Epidemiology and Clinical Research, University of Minnesota
Co-authored papers 6
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 6
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 6
N??ria Malats
Spanish National Cancer Research Centre
Co-authored papers 6
Release 1.2